Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Jun 24;256(3):337–347. doi: 10.1016/j.taap.2011.06.016

Table 1.

Jet airplane passengers

passenger
number
passenger
sex
passenger
race
phosphorylated
BChE
BChE
activity,
units/ml
number
of
flights
in the
trip
Flight
duration,
hours
destination
1a female White positive 2.7 2 6 domestic USA
1b female White negative 3.2 0 0 no airplane 6 months
2 male White positive 3.0 2 10.5 transcontinental
3a female White positive 2.4 8 25 transcontinental
3b female White negative 2.2 0 0 no airplane 3 months
4a female White positive 2.2 2 5 domestic USA
4b female White negative 2.3 0 0 no airplane 3 months
5 female White positive 3.4 4 10 domestic USA
6a female Asian positive 2.2 2 12.5 transcontinental
6b female Asian negative 3.3 0 0 no airplane 7 months
7a female Asian negative 2.6 4 9 domestic USA
7b female Asian negative 2.6 0 0 no airplane 15 months
8 female White negative 2.5 2 2.5 domestic USA
9a male White negative 1.7 5 9 domestic USA
9b male White negative 2.0 0 0 no airplane 4 months
10 male White negative 2.9 3 3 domestic USA
11 female White negative 2.7 8 17 transcontinental
12 female White negative 1.3 4 22.5 transcontinental

White passengers were non-Hispanic. Positive samples contain 0.05% to 3% phosphorylated butyrylcholinesterase (BChE). Negative samples contain less than 0.05% phosphorylated butyrylcholinesterase. Butyrylcholinesterase activity was tested in quadruplicate; the standard deviation for activity assays ranged from 1 to 5%. Four positive and two negative passengers were retested 3 to 15 months after their last jet airplane trip; results for the retested samples are in rows indicated by the letter “b”.